Jaynier Moya

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · JAMA · 2022 · 294 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +12

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · medRxiv · 2021 · 53 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Safety and immunogenicity of a zoster vaccine in varicella-zoster virus seronegative and low-seropositive healthy adults

N. Macaladad, Teodardo Marcano, Manuel Guzmán et al. · Vaccine · 2006 · 50 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

Adrienne E. Shapiro, Elias Sarkis, Jude Acloque et al. · Open Forum Infectious Diseases · 2023 · 21 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +12